Medicine
fromwww.berkeleyside.org
5 days agoBayer Berkeley gears up in the fight against Parkinson's disease
Bayer's Berkeley facility is developing bemdaneprocel, an investigational cell therapy for Parkinson's, now entering a pivotal Phase 3 trial with local manufacturing.